Result of AGM

RNS Number : 2883V

Dechra Pharmaceuticals PLC

24 October 2014

 

Date: Friday, 24 October 2014

Dechra^® Pharmaceuticals PLC

Results of Annual General Meeting (AGM)

AGM Meeting Date: 10 am on 24 October 2014

Issued Share Capital at meeting date: 87,873,605

Number of shareholders in attendance: 12

All resolutions were passed on a show of hands.

Details of the proxy voting instructions lodged prior to the AGM are set out below:

Resolution (No. as noted on proxy form)	Total For (1)		Total Against		Withheld (2)
	No. of votes	% of vote	No. of votes	% of vote	No. of votes
Resolution 1: To receive and consider the report and accounts	68,136,407	99.93	50,000	0.07	188,219
Resolution 2: To receive and approve the Directors' Remuneration Report	67,915,363	99.76	161,770	0.24	301,814
Resolution 3: To receive and approve the Directors' Remuneration Policy	66,935,753	98.32	1,140,380	1.68	302,814
Resolution 4: To declare a final dividend	68,378,647	100	0	0.00	300
Resolution 5: To re-elect Michael Redmond	68,358,227	99.97	18,470	0.03	2,250
Resolution 6: To re-elect Ian Page	68,358,227	99.97	18,470	0.03	2,250
Resolution 7: To re-elect Anne-Francoise Nesmes	68,339,364	99.95	37,333	0.05	2,250
Resolution 8: To re-elect Anthony Griffin	68,278,412	99.95	37,304	0.05	63,231
Resolution 9: To re-elect Ishbel Macpherson	68,312,715	99.91	63,982	0.09	2,250
Resolution 10: To re-elect Dr Christopher Richards	68,299,557	99.89	77,140	0.11	2,250
Resolution 11: To re-elect Julian Heslop	68,342,675	99.95	34,022	0.05	2,250
Resolution 12: To re-appoint KPMG LLP as Auditor	67,514,216	98.74	862,123	1.26	2,608
Resolution 13: To authorise the Directors to determine the remuneration of the Auditor	68,274,528	99.85	103,397	0.15	1,022
Resolution 14: To grant authority to allot shares to a specific limit	68,230,555	99.79	146,142	0.21	2,250
Resolution 15: To disapply pre-emptive rights	68,281,978	99.95	32,401	0.05	64,568
Resolution 16: To grant authority to the Company to purchase its own shares	68,284,088	99.95	31,313	0.05	63,546
Resolution 17: To call general meetings (other than an AGM) on not less than 14 clear days notice	66,943,943	98.00	1,369,208	2.00	65,796

Notes

1.   Includes discretionary votes

2.   A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of votes "For" and "Against" a resolution

3.   Resolutions 1 to 14 were ordinary resolutions, requiring more than 50% of shareholder votes to be "for" the resolutions.

4.   Resolutions 15 to 17 were special resolutions, requiring more than 75% of shareholder votes to be "for" the resolutions.

5.   Votes tendered in respect of 68,378,647 shares representing 77.81% of the issued share capital

In accordance with Listing Rule 9.6.2R, a copy of the resolutions passed as special business at the AGM have been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/nsm.

For further information

Zoe Goulding, Company Secretary

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and relates products business.  Our expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com.

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

RAGEASELAELLFFF